Bright Minds Biosciences Inc. (DRUG)

Bright Minds Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Year Ending	Current	Sep 30, 2023	Sep 30, 2022
Market Capitalization	5	6	15
Market Cap Growth	-34.95%	-58.67%	-
Enterprise Value	1	1	6
PE Ratio	-	-1.10	-1.29
PB Ratio	1.25	1.24	1.83
P/FCF Ratio	-1.63	-1.16	-1.42
P/OCF Ratio	-1.63	-1.16	-1.42
EV/EBITDA Ratio	-0.26	-0.19	-0.52
EV/EBIT Ratio	-0.26	-0.19	-0.52
EV/FCF Ratio	-0.30	-0.20	-0.57
Debt / Equity Ratio	-	-	0.01
Debt / EBITDA Ratio	-	-	0.00
Debt / FCF Ratio	-	-	-0.01
Quick Ratio	7.65	24.03	7.92
Current Ratio	7.69	24.26	8.11
Return on Equity (ROE)	-80.60%	-86.10%	-134.00%
Return on Assets (ROA)	-72.90%	-80.00%	-124.50%
Return on Capital (ROIC)	-93.07%	-111.95%	-141.08%
Earnings Yield	-74.48%	-90.48%	-77.64%
FCF Yield	-62.88%	-86.21%	-70.49%
Buyback Yield / Dilution	-17.86%	-50.57%	-37.64%
Total Shareholder Return	-17.86%	-50.57%	-37.64%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).